Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Dermatologic Manifestations of Rubella Medication

  • Author: Peter C Lombardo, MD; Chief Editor: Dirk M Elston, MD  more...
 
Updated: Oct 13, 2015
 

Medication Summary

No specific medication is available for rubella, except that given for symptomatic relief. High fever and polyarthralgia are rare in children; however, if present, acetaminophen may be used. In adults, in whom fever and polyarthralgia are more common, acetaminophen, aspirin, or other nonsteroidal anti-inflammatory drugs (NSAIDs) are useful.

Next

Analgesics, salicylate

Class Summary

These agents can reduce inflammation and fever.

Aspirin (Anacin, Ascriptin, Bayer Aspirin)

 

Aspirin treats mild to moderate pain and headache. It inhibits prostaglandin synthesis, which prevents the formation of platelet-aggregating thromboxane A2. Aspirin acts on the heat-regulating center of the hypothalamus and vasodilates peripheral vessels to reduce fever.

Previous
Next

Nonsteroidal anti-inflammatory agents

Class Summary

These agents have analgesic and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclo-oxygenase activity and prostaglandin synthesis. Other mechanisms (eg, inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, various cell membrane functions) may also exist. Although its effects in the treatment of pain tend to be patient-specific, ibuprofen is usually DOC for initial therapy.

Ibuprofen (Ibuprin, Advil, Motrin)

 

Ibuprofen is the drug of choice for mild to moderate pain. It inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. It is one of the few NSAIDs indicated for reduction of fever.

Previous
 
 
Contributor Information and Disclosures
Author

Peter C Lombardo, MD Clinical Associate Professor, Department of Dermatology, Columbia University College of Physicians and Surgeons; Private Practice, Sutton Place Dermatology, PC

Peter C Lombardo, MD is a member of the following medical societies: American Academy of Dermatology, Dermatologic Society of Greater New York, New York State Society of Dermatology and Dermatological Surgery, American Medical Association, New York Academy of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio

Van Perry, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Gregory J Raugi, MD, PhD Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle School of Medicine; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle

Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous Chief Editor, William D. James, MD, to the development and writing of this article.

References
  1. [Guideline] Centers for Disease Control and Prevention. Recommendations from an Ad Hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on Use of Alternative Diagnostic Samples for Measles and Rubella Surveillance. MMWR Morb Mort Wkly Rpt. 2008 Jun. 57(24):657-660. [Full Text].

  2. Danovaro-Holliday MC, LeBaron CW, Allensworth C, et al. A large rubella outbreak with spread from the workplace to the community. JAMA. 2000 Dec 6. 284(21):2733-9. [Medline].

  3. Centers for Disease Control and Prevention. Rubella Outbreak-Westchester County, New York 1997-1998. MMWR Morb Mort Wkly Rpt. 1999 Jul. 48(26):560-563. [Full Text].

  4. Schluter WW, Reef SE, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J Infect Dis. 1998 Sep. 178(3):636-41. [Medline].

  5. Youngdahl K. Rubella Elimination in the Americas. History of Vaccines.org. Available at http://www.historyofvaccines.org/content/blog/rubella-elimination-americas. April 30, 2015; Accessed: October 10, 2015.

  6. Giles JP, Balsamo MR, Green RH, et al. Rubella: Studies on the Natural History and Prevention of the Disease. J Pediatr. 1963. 63:816-7.

  7. American Association for Clinical Chemistry. Rubella. Lab Tests Online. Available at http://www.labtestsonline.org/. Accessed: April 8, 2009.

  8. Jensen V. Measles on the rise as vaccinations fall, study reports. Royal Holloway, University of London. August 8, 2003.

  9. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002 Nov 7. 347(19):1477-82. [Medline].

  10. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta. Pediatrics. 2004 Feb. 113(2):259-66. [Medline].

  11. Hitti M. Vaccine Court Rejects Autism Claims. WebMD Health News. February 1, 2009. [Full Text].

  12. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009 May 7. 360(19):1981-8. [Medline].

  13. American Red Cross, Centers for Disease Control and Prevention, UN Children's Fund, UN Foundation, World Health Organization. Global Measles and Rubella Strategic Plan, 2012-2020. Global Measles and Rubella Strategic Plan, 2012-2020. c2012. Available at http://www.measlesrubellainitiative.org/wp-content/uploads/2013/06/Measles-Rubella-Strategic-Plan.pdf.

  14. Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005 Aug. 24(8):665-9. [Medline].

  15. [Guideline] Centers for Disease Control and Prevention. Recommended adult immunization schedule---United States, 2009. MMWR Morb Mortal Wkly Rep. 2008. 57(53):[Full Text].

  16. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010 Jul. 126(1):e1-8. [Medline].

  17. Hviid A. Measles-mumps-rubella-varicella combination vaccine increases risk of febrile seizure. J Pediatr. 2011 Jan. 158(1):170. [Medline]. [Full Text].

  18. [Guideline] Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 May 7. 59:1-12. [Medline]. [Full Text].

  19. Gellis SE. Rubella (German measles). Fitzpatrick's Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999. Vol 2: 2395-8.

  20. Georges P, ed. Rubella. 1997 Redbook: Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 1997. 456-62.

  21. Lennette EH, Schmidt NJ. Diagnostic Procedures for Viral and Rickettsial Infections. 7th ed. Washington, DC: American Public Health Association; 1979. 725-66.

  22. Mandell GL, Bennett JE, Dolan R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: WB Saunders; 2000. 1708-14.

  23. Weedon D, Strutton G. Skin Pathology. Edinburgh, Scotland: Churchill Livingston; 1997. 597.

Previous
Next
 
Young adult with macular rash.
Child with generalized eruption.
Blueberry muffin newborn with lesions on the forehead.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.